Document is current
Any future updates will be listed below
-
Authors
Colombo, Alessio
Dinkel, Lina
Müller, Stephan A. https://orcid.org/0000-0003-3414-307X
Sebastian Monasor, Laura
Schifferer, Martina https://orcid.org/0000-0002-0500-8218
Cantuti-Castelvetri, Ludovico https://orcid.org/0000-0002-0642-1610
König, Jasmin
Vidatic, Lea
Bremova-Ertl, Tatiana
Lieberman, Andrew P.
Hecimovic, Silva
Simons, Mikael
Lichtenthaler, Stefan F.
Strupp, Michael
Schneider, Susanne A.
Tahirovic, Sabina https://orcid.org/0000-0003-4403-9559
-
Funding
Funding for this research was provided by:
Alzheimer Forschung Initiative (18014)
Alzheimer’s Association (ADSF-21-831226-C)
- License Information
-
More Information
Article History
Received: 13 August 2019
Accepted: 27 January 2021
First Online: 24 February 2021
Change Date: 12 April 2021
Change Type: Update
Change Details: Open Access funding information has been added to this article.
Competing interests
: M.Str. is Joint Chief Editor of the Journal of Neurology, Editor in Chief of Frontiers of Neuro-otology and Section Editor of F1000. He has received speaker’s honoraria from Abbott, Actelion, Auris Medical, Biogen, Eisai, Grünenthal, GSK, Henning Pharma, Interacoustics, Merck, MSD, Otometrics, Pierre-Fabre, TEVA, UCB. He is a shareholder of IntraBio. He acts as a consultant for Abbott, Actelion, AurisMedical, Heel, IntraBio, and Sensorion. T.B.E. served as a consultant for Actelion and Sanofi-Genzyme. All other authors declare that they have no competing interests.
